NEW ORLEANS--(BUSINESS WIRE)--Representatives from the Federal Home Loan Bank of Dallas (FHLB Dallas), Home Bank, Liberty Bank & Trust and Renasant Bank will award $60,000 in Partnership Grant Program (PGP) funds to the New Orleans Neighborhood Development Foundation (NDF) during a ceremonial check presentation at 11:00 a.m., Tuesday, October 28, 2025. The funds will support NDF's mission to he...
NEW ORLEANS--(BUSINESS WIRE)--Representatives from the Federal Home Loan Bank of Dallas (FHLB Dallas), Home Bank, Liberty Bank & Trust and Renasant Bank will award $60,000 in Partnership Grant Program (PGP) funds to the New Orleans Neighborhood Development Foundation (NDF) during a ceremonial check presentation at 11:00 a.m., Tuesday, October 28, 2025. The funds will support NDF's mission to he...
TUPELO, Miss., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Renasant Corporation (NYSE: RNST) (the “Company”) will announce 2025 third quarter results following the NYSE's closing on Tuesday, October 28, 2025. The Company will hold executive management's quarterly webcast and conference call with analysts on Wednesday, October 29, 2025, at 10:00 AM Eastern Time (9:00 AM Central Time).
TUPELO, Miss., Aug. 18, 2025 (GLOBE NEWSWIRE) -- The board of directors of Renasant Corporation (NYSE: RNST) approved the payment of a quarterly cash dividend of twenty-two cents ($0.22) per share to be paid September 30, 2025, to shareholders of record as of September 16, 2025.
Renasant Corporation (NYSE:RNST ) Q2 2025 Earnings Call July 23, 2025 10:00 AM ET Company Participants David L. Meredith - Executive Vice President James C.
TUPELO, Miss., July 22, 2025 (GLOBE NEWSWIRE) -- Renasant Corporation (NYSE: RNST) (the “Company”) today announced earnings results for the second quarter of 2025.
PASADENA, Calif.--(BUSINESS WIRE)-- #1031exchage--ExchangeRight, one of the nation's leading providers of diversified real estate REIT and DST investments, has announced Renasant Bank's $15 million commitment to ExchangeRight's Essential Income REIT's revolving line of credit, raising the REIT's committed capacity for its Credit Facility from $135 million to $150 million. The credit has been pr...
BERKELEY, Calif.--(BUSINESS WIRE)--Renasant Bio (Renasant), announced its launch today to advance next-generation disease-modifying treatments for autosomal dominant polycystic kidney disease (ADPKD), the leading genetic cause of end-stage renal failure. Renasant is developing a pipeline of oral small molecule corrector and first-in-class potentiator therapies that directly target the underlyin...
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.